دورية أكاديمية
أعرض في EDS

Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity.

التفاصيل البيبلوغرافية
العنوان: Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity.
المؤلفون: Shnayder NA; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia.; Shared Core Facilities 'Molecular and Cell Technologies', V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia., Novitsky MA; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia., Neznanov NG; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia.; Department of Psychiatry and Addiction, I.M. Pavlov First Saint Petersburg State Medical University, 197022 Saint Petersburg, Russia., Limankin OV; P.P. Kashchenko Saint Petersburg Psychiatric Hospital No. 1, Gatchinsky District, 190005 Leningrad, Russia.; Department of Psychotherapy and Sexual Medicine, I.I. Mechnikov North-Western State University, 191015 Saint Petersburg, Russia.; Department of Social Psychiatry and Psychology, Saint Petersburg Postgraduate Institute of Medical Experts, 194044 Saint Petersburg, Russia., Asadullin AR; Department of Psychiatry and Addiction, Bashkir State Medical University, 450008 Ufa, Russia., Petrov AV; Shared Core Facilities 'Molecular and Cell Technologies', V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia., Dmitrenko DV; Shared Core Facilities 'Molecular and Cell Technologies', V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia., Narodova EA; Shared Core Facilities 'Molecular and Cell Technologies', V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia., Popenko NV; Shared Core Facilities 'Molecular and Cell Technologies', V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, Russia., Nasyrova RF; Institute of Personalized Psychiatry and Neurology, Shared Core Facilities, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint Petersburg, Russia.; International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, 443099 Samara, Russia.
المصدر: Genes [Genes (Basel)] 2022 Mar 02; Vol. 13 (3). Date of Electronic Publication: 2022 Mar 02.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI
مواضيع طبية MeSH: Depressive Disorder, Major*/genetics , Schizophrenia*/epidemiology , Schizophrenia*/genetics, Comorbidity ; Genetic Predisposition to Disease ; Humans ; Multifactorial Inheritance ; Transcription Factors/genetics
مستخلص: Background : Patients with schizophrenia have an increased risk of depressive disorders compared to the general population. The comorbidity between schizophrenia and depression suggests a potential coincidence of the pathophysiology and/or genetic predictors of these mental disorders. The aim of this study was to review the potential genetic predictors of schizophrenia and depression comorbidity. Materials and Methods : We carried out research and analysis of publications in the databases PubMed, Springer, Wiley Online Library, Taylor & Francis Online, Science Direct, and eLIBRARY.RU using keywords and their combinations. The search depth was the last 10 years (2010-2020). Full-text original articles, reviews, meta-analyses, and clinical observations were analyzed. A total of 459 articles were found, of which 45 articles corresponding to the purpose of this study were analyzed in this topic review. Results : Overlap in the symptoms and genetic predictors between these disorders suggests that a common etiological mechanism may underlie the presentation of comorbid depression in schizophrenia. The molecular mechanisms linking schizophrenia and depression are polygenic. The most studied candidate genes are GRIN1 , GPM6A , SEPTIN4 , TPH1 , TPH2 , CACNA1C , CACNB2 , and BCL9. Conclusion : Planning and conducting genome-wide and associative genetic studies of the comorbid conditions under consideration in psychiatry is important for the development of biological and clinical predictors and a personalized therapy strategy for schizophrenia. However, it should be recognized that the problems of predictive and personalized psychiatry in the diagnosis and treatment of schizophrenia and comorbid disorders are far from being resolved.
References: Mol Cell Proteomics. 2014 Feb;13(2):397-406. (PMID: 24309898)
Mol Biol Res Commun. 2015 Jan;4(1):33-42. (PMID: 27843994)
Am J Psychiatry. 1988 Dec;145(12):1532-7. (PMID: 3057924)
Neuron. 1992 Jan;8(1):71-84. (PMID: 1309651)
Mol Psychiatry. 2004 May;9(5):442-73. (PMID: 15037866)
Am J Psychiatry. 2002 Nov;159(11):1855-61. (PMID: 12411219)
Nat Methods. 2013 May;10(5):413-20. (PMID: 23524393)
Front Neurosci. 2020 Mar 11;14:115. (PMID: 32218718)
Pharmacol Rep. 2021 Feb;73(1):309-315. (PMID: 33025395)
Science. 2004 Jul 9;305(5681):217. (PMID: 15247473)
Hum Genet. 2007 Nov;122(3-4):409-11. (PMID: 17653577)
Am J Addict. 2006 Sep-Oct;15(5):345-55. (PMID: 16966190)
Nervenarzt. 2013 Sep;84(9):1093-4, 1096-103. (PMID: 23695002)
Mol Psychiatry. 2005 Sep;10(9):884-8, 805. (PMID: 16044172)
Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):87-91. (PMID: 14681922)
Br J Psychiatry. 2000 Dec;177:516-21. (PMID: 11102326)
Lancet. 2013 Nov 9;382(9904):1575-86. (PMID: 23993280)
Dev Dyn. 2008 Sep;237(9):2415-29. (PMID: 18729205)
Acta Psychiatr Scand. 2010 Sep;122(3):211-8. (PMID: 19922525)
Mol Psychiatry. 2005 Nov;10(11):976-7. (PMID: 16027738)
Arch Gen Psychiatry. 2011 Mar;68(3):232-40. (PMID: 21383261)
Acta Psychiatr Scand. 1999 Aug;100(2):105-18. (PMID: 10480196)
Schizophr Res. 2005 Sep 1;77(1):11-24. (PMID: 16005381)
Neuron. 2005 Jan 6;45(1):11-6. (PMID: 15629698)
Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):707-11. (PMID: 18163405)
Compr Psychiatry. 2006 Nov-Dec;47(6):438-42. (PMID: 17067866)
Cell. 1999 Aug 20;98(4):427-36. (PMID: 10481908)
Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):174-84. (PMID: 15995901)
Neuroscience. 2015 Jul 23;299:1-17. (PMID: 25934039)
Arch Gen Psychiatry. 1976 Feb;33(2):231-9. (PMID: 766720)
Schizophr Res. 2003 Mar 1;60(1):21-32. (PMID: 12505135)
Psychiatry Investig. 2014 Jul;11(3):281-9. (PMID: 25110501)
PLoS Genet. 2014 Jun 05;10(6):e1004345. (PMID: 24901509)
J Neurosci. 2020 Apr 15;40(16):3304-3317. (PMID: 32205341)
Pharmacol Ther. 2020 Jan;205:107426. (PMID: 31629007)
Int J Risk Saf Med. 2015;27 Suppl 1:S89-90. (PMID: 26639728)
Mol Psychiatry. 2001 May;6(3):268-73. (PMID: 11326294)
Hum Mol Genet. 2008 Jan 1;17(1):87-97. (PMID: 17905754)
Front Synaptic Neurosci. 2020 Jul 23;12:28. (PMID: 32848694)
Schizophr Bull. 2009 Mar;35(2):383-402. (PMID: 19011234)
Schizophr Bull. 2008 Jan;34(1):109-17. (PMID: 17515440)
J Neurochem. 2015 Aug;134(3):499-512. (PMID: 25940868)
Pharmacol Rep. 2021 Feb;73(1):269-277. (PMID: 33237434)
J Ment Health Policy Econ. 2013 Mar;16(1):13-25. (PMID: 23676412)
Soc Psychiatry Psychiatr Epidemiol. 2013 Jul;48(7):1021-31. (PMID: 23644725)
Sci Rep. 2015 Oct 23;5:15705. (PMID: 26494551)
J Nerv Ment Dis. 1987 Feb;175(2):100-5. (PMID: 2879880)
Expert Rev Neurother. 2012 Jan;12(1):1-3. (PMID: 22243039)
Compr Psychiatry. 2011 Sep-Oct;52(5):479-85. (PMID: 21185016)
BMC Psychiatry. 2013 Apr 05;13:106. (PMID: 23560591)
Br J Psychiatry. 2009 Sep;195(3):242-8. (PMID: 19721115)
Int J Epidemiol. 2008 Feb;37(1):120-32. (PMID: 17898028)
Psychiatr Genet. 2007 Oct;17(5):308-10. (PMID: 17728671)
Br J Psychiatry. 1981 Aug;139:89-101. (PMID: 7030447)
Int J Geriatr Psychiatry. 2014 Aug;29(8):789-96. (PMID: 25191689)
Lancet. 2013 Apr 20;381(9875):1371-1379. (PMID: 23453885)
J Med Genet. 2006 Jul;43(7):563-7. (PMID: 16227524)
Nagoya J Med Sci. 2002 Nov;65(3-4):115-26. (PMID: 12580538)
Front Psychiatry. 2015 Feb 18;6:13. (PMID: 25762938)
Nat Genet. 2008 Jul;40(7):827-34. (PMID: 18583979)
Front Behav Neurosci. 2019 Jan 10;12:332. (PMID: 30687034)
Schizophr Res. 2007 Nov;96(1-3):257-66. (PMID: 17644312)
Schizophr Bull. 2014 Nov;40(6):1285-99. (PMID: 24664977)
Schizophr Res. 2014 Oct;159(1):243-8. (PMID: 25171855)
PLoS One. 2013;8(1):e51674. (PMID: 23382809)
World J Biol Psychiatry. 2005;6(4):247-63. (PMID: 16272080)
Aust N Z J Psychiatry. 2002 Dec;36(6):733-42. (PMID: 12406115)
Arch Gen Psychiatry. 1991 Dec;48(12):1075-81. (PMID: 1845225)
Schizophr Bull. 1994;20(2):327-38. (PMID: 8085135)
Transl Psychiatry. 2018 Mar 15;8(1):67. (PMID: 29540662)
Mol Cell Neurosci. 2016 Dec;77:95-104. (PMID: 27793698)
Front Synaptic Neurosci. 2021 May 04;13:661681. (PMID: 34017241)
Schizophr Bull. 2019 Jan 1;45(1):138-147. (PMID: 29394409)
BMC Med Genet. 2019 Jan 31;20(1):26. (PMID: 30704411)
Hum Genet. 2006 Apr;119(3):233-40. (PMID: 16450114)
Eur J Med Res. 2011 Dec 2;16(12):549-52. (PMID: 22112362)
فهرسة مساهمة: Keywords: comorbidity; depression; genetics; pathophysiology; predictor; schizophrenia
المشرفين على المادة: 0 (BCL9 protein, human)
0 (Transcription Factors)
تواريخ الأحداث: Date Created: 20220325 Date Completed: 20220427 Latest Revision: 20220427
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8950769
DOI: 10.3390/genes13030457
PMID: 35328011
قاعدة البيانات: MEDLINE
الوصف
تدمد:2073-4425
DOI:10.3390/genes13030457